Delving into the Latest Updates on Resurge Therapeutics, Inc. with Synapse

概览

排名前五的药物类型	数量

小分子化药	1

关联

1

项与 Resurge Therapeutics, Inc. 相关的药物

RT-310

靶点-

作用机制-

在研机构

Resurge Therapeutics, Inc.

原研机构

Resurge Therapeutics, Inc.

在研适应症

下尿路症状 [+1]

非在研适应症-

最高研发阶段临床1期

首次获批国家/地区-

首次获批日期-

1

项与 Resurge Therapeutics, Inc. 相关的临床试验

NCT06136819

/ Recruiting临床1期

Safety and Feasibility Dose Escalation Study for Evaluation of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)

RT-310, a novel implant, is intended to minimally invasive treat locally the prostate gland for the management of prostate disease, while minimizing side-effects. The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.

开始日期2024-04-19

申办/合作机构

Resurge Therapeutics, Inc.

100 项与 Resurge Therapeutics, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Resurge Therapeutics, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Resurge Therapeutics, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Resurge Therapeutics, Inc. 相关的转化医学

登录后查看更多信息